INDIAN HARBOUR BEACH, FL, November 02, 2009
/24-7PressRelease/ -- Mushatt's LLC today announced that it will donate 2% of its sales revenue to support the National Psoriasis Foundation Research Program.
Research is the top priority of The National Psoriasis Foundation, whose efforts are aimed at searching for better treatments and a cure for psoriasis.
Psoriasis is a non-contagious, genetic disease of the immune system and manifests itself in the skin and/or joints of the body. It affects about 2% of the population or 7,500,000 people in the United States alone.
"As today is World Psoriasis Day -- Mushatt's is especially pleased to play its part in helping find long-term solutions for the millions of sufferers of this debilitating disease, which very often has a significant impact on quality of life. The National Psoriasis Foundation's efforts have been a lone voice in advocating for support and Mushatts hopes that its contribution will be part of a growing movement to build greater awareness of Psoriasis and develop sustainable treatment solutions for this chronic skin disease", Michael Foley, President/CEO, Mushatt's LLC said today in Indian Harbour Beach, Florida-home of the Mushatt's organization in the U.S.
Inspired and developed in Ireland in 1922, Mushatt's No. 9 range of skin care products include
Psoriasis Skin Ointment,
Psoriasis Facial Cream,
Psoriasis Scalp Cream, and
PsoriWash a non-detergent, non-soap, non-foaming wash formulated specifically for psoriasis. All the Mushatt's No. 9 products are steroid free and are manufactured in the U.S. in an FDA-and GMP-approved state-of-the-art facility.
For more information about Mushatt's please visit
www.mushatts.com or email us at
info@mushatts.com or call 321-626-0600.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Press Release Keywords:- psoriasis, soriasis, eczema, mushatts, dry skin, skin care, skin disease, dermatitis, psoriasis cream, psoriasis lotion, psoriasis ointment, psoriasis soap
Other Press Release Headlines: